companydata.dkSalient Pharma ApS: Financial statements 2017
CVR: 36900709
Salient Pharma ApS (CVR 36900709) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -1,244,332 and a net result of DKK -970,745 compared with DKK -772,477 the year before. Equity amounted to DKK -1,817,960.
- Gross Profit
- -1,244,332 kr.
- Profit/Loss
- -970,745 kr.
- Equity
- -1,817,960 kr.
- Total Assets
- 398,842 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -1.2 mio. | -971 t. | -1.8 mio. | - |
| 2016 | - | -955 t. | -772 t. | -847 t. | - |
Find more companies like Salient Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
Salient Pharma ApS has published its annual report for 2016. Gross profit came to DKK -954,993, and the net result was DKK -772,477.
About Salient Pharma ApS
Salient Pharma ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Ulrik Spork. The company is owned by HB-MEDICAL HOLDING ApS, CAND.PHARM. POVL M. ASSENS FOND and SPORCON LIFESCIENCE ADVISORS ApS. In 2025, the company reported a gross profit of DKK -129,889 and a net result of DKK -218,345 compared with DKK -202,180 the year before. Equity amounted to DKK -1,344,010.